Please provide your email address to receive an email when new articles are posted on . The medical community has long recognized the strong correlation between diabetes and heart disease. Compounding ...
Oral semaglutide, the first glucagon-like peptide 1 (GLP-1) receptor agonist in a pill, met safety benchmarks and reduced major cardiovascular (CV) events for high-risk patients with type 2 diabetes ...
Among men with testosterone deficiency, users vs nonusers of testosterone therapy did not show differences in cardiovascular safety outcomes. In real-world clinical practice, long-term testosterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results